Core Concepts · Related to Chapter 9

The Origami That Won the Nobel: What AlphaFold Changes for Your Treatment

The Origami That Won the Nobel: What AlphaFold Changes for Your Treatment

By André Leite and Vinícius Lain, authors of AI in Healthcare.

Every protein in the human body starts as a linear sequence of amino acids, a sort of ribbon, and has to fold into a specific three-dimensional shape in order to work. This folding is so complex that for decades, predicting a protein's final shape from its sequence alone was considered one of the great unsolved problems in biology. It was something like trying to guess, just by looking at a flat sheet of paper, exactly which origami figure it will become after hundreds of folds.

In 2024, the Nobel Prize in Chemistry recognized the people who solved a large part of that problem: an artificial intelligence system able to predict, with previously unthinkable accuracy, the three-dimensional structure of proteins from their genetic sequence. The impact on medicine is hard to overstate. Understanding a protein's exact shape is the first step to understanding how a disease shows up at the molecular level and, above all, to designing drugs that fit it precisely, like a key cut for one specific lock.

This advance connects directly to another concept that was already growing before AlphaFold: pharmacogenomics, the study of how each person's genetics influences their response to a drug. Two people with the same diagnosis, given the same dose of the same medication, can respond in completely different ways. One benefits, another feels nothing, a third suffers a serious side effect. The promise of so-called "N-of-1" medicine is exactly this: treating each patient as a sample of one, tailoring therapy to their individual genetics instead of applying protocols designed for the average of a population.

None of this is distant science fiction. It is the direct result of artificial intelligence applied to a problem that human science, on its own, spent decades failing to solve, and then solved decisively once it got the right computational help. The road from this breakthrough to the exam room still has stages (regulation, cost, access), but the direction is set: the future of personalized treatment depends, in large part, on algorithms that can do in minutes what biology would take generations to figure out on its own.

André Leite Vinícius Lain
André Leite and Vinícius Lain, authors of AI in Healthcare.
André Leite · Vinícius Lain

Discover the book

Keep reading

Explore by theme · Explore by chapter · All articles